Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Folch solution" patented technology

Folch solution is a solution containing chloroform and methanol, usually in a 2:1 (vol/vol) ratio. One of its uses is in separating polar from nonpolar compounds, for example separating nonpolar lipids from polar proteins and carbohydrates in blood serum.

Method for detecting related substances of dapagliflozin tablets

The invention discloses a method for detecting related substances of dapagliflozin tablets, and belongs to the technical field of medicine detection. The related substances comprise an impurity 383-1D, an impurity 383-1E, an impurity 383-1F and an impurity 383-1G, and the detection method comprises the following detection conditions: adopting a high performance liquid chromatography method, taking octadecyl silica gel as a chromatographic column, taking potassium hydrogen phosphate as a buffer solution, taking acetonitrile as a diluted solution, taking a methanol-water solution as a mobile phase A, taking an acetonitrile-water solution as a mobile phase B, carrying out gradient elution, and carrying out gradient elution to obtain the impurity 383-1D, impurity 383-1E, impurity 383-1F and impurity 383-1G. And separating the related substances of the dapagliflozin tablet, and detecting to obtain the amount of the related substances. By detecting the amount of related substances, the production of the related substances in the production process is controlled, so that the product quality of the medicine is guaranteed.
Owner:HAINAN HUALON PHARM

Stable ready to dilute composition of carfilzomib

The invention is directed to room temperature stable injectable formulations of carfilzomib or its pharmaceutically acceptable derivatives thereof in the form of ready to dilute solution and concentrates with no hemolytic potential. Further the invention is directed to a method for treating patients with relapsed or refractory multiple myeloma by administering such composition.
Owner:ACQUIOM AGENCY SERVICES LLC AS COLLATERAL AGENT

Nano-composite for delivering rapamycin based on targeted peptide modified gold nanoparticles as well as preparation method and application of nano-composite

The invention discloses a nano compound (RAP (at) KTP (at) AuNPs) for delivering rapamycin based on targeted peptide modified gold nanoparticles as well as a preparation method and application of the nano compound. In the nano compound, the surfaces of the gold nanoparticles are modified by polyethylene glycol to form a PEG layer; the K3 targeting peptide is connected to the surface of the PEG layer through non-covalent coupling; rapamycin is loaded and wrapped in the PEG layer. SH-PEG-SH is added into the AuNPs solution, and a PEG modified AuNPs solution is obtained through a reaction; diluting the K3 targeting peptide with pure water to obtain a diluted solution, adding the diluted solution into the PEG-modified AuNPs solution, and reacting to obtain a KTP-coated AuNPs solution; the preparation method comprises the following steps: dissolving rapamycin powder by using dimethyl sulfoxide, adding the rapamycin powder into a KTP (at) AuNPs solution, and reacting to obtain the nano-composite RAP (at) KTP (at) AuNPs. The nanocomposite provided by the invention can realize efficient and accurate delivery of rapamycin, and improves the effect of treating renal fibrosis.
Owner:SHANXI MEDICAL UNIV

Kit for detecting glycoprotein

Provided is a kit for detecting a glycoprotein contained in a sample using an optical condensation system, the kit comprising microparticles modified by host molecules and a dilution solution for diluting the sample, in which each of the host molecules binds specifically to the glycoprotein, the dilution solution comprises a blocking agent and a buffering agent, the pH value of the dilution solution is higher than the isoelectric point of the glycoprotein, the concentration of the blocking agent is lower than a concentration at which the non-specific adsorption between the host molecules is inhibited in an environment where a light-induced force does not act on the host molecules, and the salt concentration in the dilution solution is a concentration at which the microparticles modified by the host molecules cannot be precipitated by salting out.
Owner:PUBLIC UNIVERSITY CORPORATION OSAKA CITY UNIVERSITY +1